 |
|
Atypical hemolytic uremic syndrome and eculizumab therapy in children
Seong Heon Kim (Kim SH), Hye Young Kim (Kim HY), Su Young Kim (Kim SY)
Clin Exp Pediatr. 2018;61(2):37-42. Published online 2018 Feb 28 DOI: https://doi.org/10.3345/kjp.2018.61.2.37
|
|
Citations to this article as recorded by
 Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
Monika Vitkauskaitė, Artūras Vinikovas, Marius Miglinas, Laurynas Rimševičius, Agnė Čerkauskaitė, Ernesta Mačionienė, Eglė Ašakienė
Clinical Case Reports.2022;[Epub] CrossRef Nephrotic syndrome associated with primary atypical hemolytic uremic syndrome
Diana Carolina Bello-Marquez, John Fredy Nieto-Rios, Lina Maria Serna-Higuita, Alfonso Jose Gonzalez-Vergara
Brazilian Journal of Nephrology.2021; 43(3): 440. CrossRef Use of eculizumab in atypical uremic hemolytic syndrome in childhood: case report
Maria Goretti Moreira Guimarães Penido, Mariana Marta de Oliveira Antunes
Urology & Nephrology Open Access Journal.2020; 8(3): 75. CrossRef
|